A Mathematical Model to Optimize the Neoadjuvant Chemotherapy Treatment Sequence for Triple-Negative Locally Advanced Breast Cancer
Background: Triple-negative locally advanced breast cancer is an aggressive tumor type. Currently, the standard sequence treatment is applied, administering anthracyclines first and then a taxane plus platinum. Clinical studies for all possible treatment combinations are not practical or affordable,...
Main Authors: | Juan C. López-Alvarenga, Antonmaria Minzoni-Alessio, Arturo Olvera-Chávez, Gustavo Cruz-Pacheco, Juan C. Chimal-Eguia, Joselín Hernández-Ruíz, Mario A. Álvarez-Blanco, María Y. Bautista-Hernández, Rosa M. Quispe-Siccha |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | Mathematics |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-7390/11/11/2410 |
Similar Items
-
Efficacy and safety of Anlotinib based neoadjuvant chemotherapy for locally advanced triple negative breast cancer (TNBC)
by: Kuojun Ren, et al.
Published: (2024-10-01) -
Comprehensive genomic profiling can predict response to neoadjuvant chemotherapy in triple-negative breast cancer
by: Monika Drobniene, et al.
Published: (2025-04-01) -
Therapeutic Pattern and Progress of Neoadjuvant Treatment for Early Stage Triple-negative Breast Cancer
by: XIU Meng, et al.
Published: (2020-02-01) -
Does T1c–2N0–1M0 triple negative breast cancer derive a benefit from neoadjuvant chemotherapy?
by: Ruiliang Chen, et al.
Published: (2024-12-01) -
COMPARATIVE ANALYSIS OF DIFFERENT NEOADJUVANT CHEMOTHERAPY REGIMENS FOR TRIPLE-NEGATIVE BREAST CANCER
by: P. V. Krivorotko, et al.
Published: (2017-12-01)